nasal spray Archives - Express Pharma

Glenmark receives US FDA approval to expand the use of RYALTRIS nasal spray for children aged 6 to less than 12 years

Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US

ARS Pharmaceuticals’ Neffy poised to disrupt epinephrine market as first needle-free nasal spray: GlobalData

FDA denies approval for Orexo AB’s high-dose Opioid rescue nasal spray, OX124

Glenmark and Lotus enter into partnership for Ryaltris in key South East Asian markets

Glenmark gets US FDA nod for nasal spray to treat seasonal allergic rhinitis

Glenmark receives marketing approval for its nasal spray in 13 countries across EU and UK

Glenmark’s Ryaltris nasal spray gets approval in Europe for treatment of allergic rhinitis

Glenmark, Bausch Health partner to commercialise RYALTRIS nasal spray in Canada

Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia